Is Sanara Medtech Inc (SMTI) overvalued? · rev $55.9M
Sanara Medtech Inc (SMTI) is a medical instruments & supplies company listed on US.
This page asks whether Sanara Medtech Inc (SMTI) looks expensive on cached numbers — not a short thesis.
Latest reported SMTI revenue for 2026-06-30 was $55.9M. Net income was $6.1K. SMTI currently screens at market cap $263.5M.
SMTI currently screens at market cap $263.5M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SMTI 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SMTI stock page for the full model, not this heading.
Not investment advice.